Branson Pharma AG

bransonpharma.comBaar, Switzerland
2 profile visits

About

  • Branson Pharma develop a bio molecule that demonstrates a high efficacy and speed to eliminate a range of infections related to gynecologic conditions in uterus and fallopian tubes (endometritis, endometriosis, adenomyosis, etc.)

  • The molecule specifically targets infected cells only, dissolving dead and infected tissue by breaking any infection down into basic amino acids and removing them

  • Early tests demonstrated a significant efficacy closer to 100% treatment rate

  • At Branson Pharma we believe the final product can be called a cure

  • Cost effective to produce

  • We are now open to discuss co-investment options and to decide on locating future manufacuring in the EU

Representatives

Alexey Borozna

CEO

Branson Pharma AG

Marketplace (1)